awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38254893-04CE6773-7120-497B-96BE-F8F6C4C1204E
Q38254893-04CE6773-7120-497B-96BE-F8F6C4C1204E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38254893-04CE6773-7120-497B-96BE-F8F6C4C1204E
Quality of life in MPN comes of age as a therapeutic target.
P2860
Q38254893-04CE6773-7120-497B-96BE-F8F6C4C1204E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38254893-04CE6773-7120-497B-96BE-F8F6C4C1204E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
28d9670a0cd70ba664a8a46d33bb1ebf4c383ef7
P2860
Long-term outcomes of 107 patients with myelofibrosis receiving JAK1/JAK2 inhibitor ruxolitinib: survival advantage in comparison to matched historical controls